Venetoclax and Blinatumomab for adult patients with relapsed/refractory or MRD positive Ph-negative B-cell precursor ALL: phase I part of the GMALL-BLIVEN trial.
Saved in:
| Title: | Venetoclax and Blinatumomab for adult patients with relapsed/refractory or MRD positive Ph-negative B-cell precursor ALL: phase I part of the GMALL-BLIVEN trial. |
|---|---|
| Authors: | Fransecky, Lars, Fiedler, Walter, Röllig, Christoph, Sauer, Tim, Raffel, Simon, Alsdorf, Winfried, Heberling, Lisa, Steer, Britta, Huber, Karin, Versteegen, Tim, Spory, Lea, Deckbar, Dorothee, Reiser, Lena, Bendig, Sonja, Bastian, Lorenz, Bozzetti, Cecilia, Beder, Thomas, Neumann, Martin, Brüggemann, Monika, Gökbuget, Nicola, et al |
| Source: | Annals of hematology Mar2026; Vol. 105 (3). |
| Journal Info: | Publisher: Springer Nature ISSN: 0939-5555 |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
